\
&
Contact us
\
&
Contact us
This was 1 year ago
LocationHybrid - Brussels and online
The Horizon Europe Cluster 3 – Civil Security for society – Info Day and Brokerage Event will provide information on the topics of the calls that are due to open on 27 June 2024, and how to apply, as well as networking opportunities.
The event is organised by the Cluster 3 NCP network SEREN5, in close cooperation with the European Commission’s Directorate-General for Migration and Home Affairs (DG HOME) and the European Research Executive Agency (REA).
Register on the Security Research Database to find partners and follow updates on the website of SEREN5.
More information is also already available through the recording of the pre-info day that took place on 22 March 2024.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space Climate, Energy, Mobility
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
